DRREDDY₹1,229.50-0.77%
40/100
0100 · strongest
moderate
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %DRREDDY financial summary
For Mar 2026, Dr Reddys Laboratories Ltd reported revenue of ₹20,533 crore, which fell 11.2% from the previous year. Net profit was ₹3,220 crore, which fell 39.8% year on year, on an operating margin of 19%. Earnings per share came in at ₹38.58. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹20,533 crore |
|---|---|
| Net profit | ₹3,220 crore |
| Operating margin | 19% |
| EPS | ₹38.58 |